Home / Featured Companies / Gilead Sciences Historical Data

Gilead Sciences (GILD) Financials

Gilead Sciences (GILD) Historical Financial Statements and Key Metrics for 1996 - 2021

Full Gilead Sciences financials for 1996 - 2021 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Gilead Sciences Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2021-Mar-31 6,423 5,062 (78.8 %) 2,952 (46.0 %) 1,729 (26.9 %) 3,425 1.37
2020-Dec-31 7,421 6,023 (81.2 %) 2,715 (36.6 %) 1,551 (20.9 %) 3,142 1.24
2020-Sep-30 6,577 5,436 (82.7 %) 3,172 (48.2 %) 360 (5.5 %) 3,527 0.29
2020-Jun-30 5,143 4,079 (79.3 %) -2,983 (-58.0 %) -3,339 (-64.9 %) -2,634 -2.66
2020-Mar-31 5,548 4,579 (82.5 %) 2,402 (43.3 %) 1,551 (28.0 %) 2,751 1.22
2019-Dec-31 5,879 4,196 (71.4 %) 1,093 (18.6 %) 2,696 (45.9 %) 1,443 2.12
2019-Sep-30 5,604 4,569 (81.5 %) -1,473 (-26.3 %) -1,165 (-20.8 %) -1,126 -0.92
Full historical income statements for 1996 - 2021 is included in the US Historical Financials dataset.

Gilead Sciences Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2021-Mar-31 67,492 48,528 30,166 18,952 5,666
2020-Dec-31 68,407 50,186 31,402 18,202 7,408
2020-Sep-30 60,878 43,407 29,290 17,445 23,975
2020-Jun-30 55,934 37,792 24,102 18,027 18,914
2020-Mar-31 59,741 37,562 24,097 22,067 20,785
2019-Dec-31 61,627 38,977 24,593 22,525 24,352
2019-Sep-30 59,146 38,410 24,588 20,604 22,856
Full historical balance sheet data for 1996 - 2021 is included in the US Historical Financials dataset.

Gilead Sciences Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2021-Mar-31 2,610 -2,042 -2,477 2,445
2020-Dec-31 1,916 -8,977 131 1,735
2020-Sep-30 2,250 -271 4,124 2,095
2020-Jun-30 2,566 -5,023 -874 2,423
2020-Mar-31 1,436 -344 -2,611 1,265
2019-Dec-31 2,580 431 -896 2,377
2019-Sep-30 2,899 -2,095 -2,515 2,699
Full historical cash flow data for 1996 - 2021 is included in the US Historical Financials dataset.

Gilead Sciences Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2021-Mar-31 81,175 107,276 12.64 11.74 4.28
2020-Dec-31 73,116 98,521 9.85 11.79 4.02
2020-Sep-30 79,303 95,707 12.06 55.07 4.55
2020-Jun-30 96,560 113,916 18.77 -7.23 5.36
2020-Mar-31 94,347 108,393 17.01 15.21 4.28
2019-Dec-31 82,265 95,227 13.99 7.63 3.65
2019-Sep-30 80,302 95,416 14.33 -17.23 3.90
Full historical valuation and operating metrics for 1996 - 2021 are included in the US Historical Financials dataset.